| Literature DB >> 26046433 |
Cullen Taniguchi1, Anirban Maitra2.
Abstract
DPC4/SMAD4 mutations are associated with aggressive pancreatic cancer. In this issue of Cell, Whittle et al. demonstrate that Runx3 expression combined with Dpc4/Smad4 status can predict the metastatic propensity of pancreatic tumors, providing valuable guidance for personalized therapy for patients with pancreatic cancer.Entities:
Mesh：
Substances：
Year: 2015 PMID： 26046433 DOI： 10.1016/j.cell.2015.05.030
Source DB: PubMed Journal: Cell ISSN： 0092-8674 Impact factor: 41.582